Frontier Capital Management’s Idexx Laboratories IDXX Stock Holding History

Frontier Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.7M	Sell	33,592 -1,772	-5%	-$994K	0.16%	199
2026 Q1	$19.9M	Sell	35,364 -9,979	-22%	-$6.4M	0.2%	166
2025 Q4	$30.7M	Sell	45,343 -62,959	-58%	-$42.9M	0.33%	112
2025 Q3	$69.2M	Sell	108,302 -763	-0.7%	-$463K	0.62%	39
2025 Q2	$58.5M	Sell	109,065 -6,851	-6%	-$3.28M	0.54%	57
2025 Q1	$48.7M	Buy	115,916 +25,787	+29%	+$11.2M	0.53%	61
2024 Q4	$37.3M	Sell	90,129 -50,466	-36%	-$22.1M	0.35%	111
2024 Q3	$71M	Sell	140,595 -3,692	-3%	-$1.79M	0.67%	40
2024 Q2	$70.3M	Sell	144,287 -6,795	-4%	-$3.41M	0.7%	31
2024 Q1	$81.6M	Sell	151,082 -4,618	-3%	-$2.52M	0.76%	31
2023 Q4	$86.4M	Sell	155,700 -3,314	-2%	-$1.56M	0.87%	26
2023 Q3	$69.5M	Sell	159,014 -1,298	-0.8%	-$647K	0.76%	30
2023 Q2	$80.5M	Buy	160,312 +4,514	+3%	+$2.16M	0.77%	36
2023 Q1	$77.9M	Buy	155,798 +43,042	+38%	+$20.6M	0.81%	37
2022 Q4	$46M	Sell	112,756 -3,788	-3%	-$1.47M	0.5%	67
2022 Q3	$38M	Sell	116,544 -6,096	-5%	-$2.24M	0.45%	72
2022 Q2	$43M	Buy	122,640 +11,497	+10%	+$4.69M	0.5%	68
2022 Q1	$60.8M	Sell	111,143 -17,492	-14%	-$9.2M	0.55%	55
2021 Q4	$84.7M	Sell	128,635 -19,036	-13%	-$11.9M	0.67%	42
2021 Q3	$91.8M	Sell	147,671 -11,815	-7%	-$7.94M	0.72%	36
2021 Q2	$101M	Sell	159,486 -20,518	-11%	-$11.3M	0.74%	34
2021 Q1	$88.1M	Sell	180,004 -37,370	-17%	-$18.7M	0.67%	42
2020 Q4	$109M	Buy	217,374 +23,443	+12%	+$10.5M	0.8%	32
2020 Q3	$76.2M	Sell	193,931 -14,960	-7%	-$5.53M	0.67%	43
2020 Q2	$69M	Buy	208,891 +48,373	+30%	+$14M	0.61%	52
2020 Q1	$38.9M	Sell	160,518 -24,318	-13%	-$6.35M	0.44%	80
2019 Q4	$48.3M	Sell	184,836 -48,266	-21%	-$12.7M	0.36%	105
2019 Q3	$63.4M	Buy	233,102 +46,990	+25%	+$13.1M	0.5%	70
2019 Q2	$51.2M	Sell	186,112 -5,337	-3%	-$1.31M	0.39%	102
2019 Q1	$42.8M	Buy	+191,449	New	+$39.5M	0.3%	131

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Frontier Capital Management's IDXX Position: Q2 2026 in Review

Frontier Capital Management reduced its Idexx Laboratories (IDXX) stake by 5% in Q2 2026, selling an estimated $994K and leaving 33,592 shares worth $17.7M. The position accounts for 0.16% of the portfolio, ranked #199.

Frontier Capital Management first reported a position in IDXX in Q1 2019 and has held it in 30 quarters since. The position peaked at $109M in Q4 2020. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Frontier Capital Management held 33,592 shares of Idexx Laboratories worth $17.7M as of Q2 2026.
Frontier Capital Management sold 1,772 Idexx Laboratories shares in Q2 2026, an estimated $994K.
Idexx Laboratories made up 0.16% of Frontier Capital Management's portfolio in Q2 2026, its #199 holding.
Frontier Capital Management first reported a position in Idexx Laboratories in Q1 2019 and has held it in 30 quarters since.
Frontier Capital Management's Idexx Laboratories position peaked at $109M in Q4 2020.
1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.